期刊文献+

鼻咽淋巴瘤临床特征及其与肿瘤微环境的关系

Clinical characteristic of nasopharyngeal lymphoma and its association with tumor microenvironment
下载PDF
导出
摘要 既往文献常将发生于鼻咽部的淋巴瘤归入鼻腔淋巴瘤进行研究和报道,但鼻咽淋巴瘤可能有其独有的临床表现和病理特点,预后与鼻腔淋巴瘤亦存在差异。炎症与肿瘤微环境在肿瘤发生、发展中的作用是近年来肿瘤研究领域的一个热点,这类指标获取容易,且便于动态监测。为此,特将鼻咽淋巴瘤的临床特征、肿瘤微环境和外周血炎症指标与鼻咽淋巴瘤的预后关系予以综述。 The primary nasopharyngeal lymphoma(NPL)has often been classified as the primary nasal lymphoma(NSL)in many previous literatures.However,special characteristics of clinical manifestations and pathology could be found in NPL,and the differences also existed in prognosis between NPL and NSL.More and more research showed that inflammatory and tumor microenvironment might play an important role in the occurrence and progress of malignant tumors.These inflammatory indicators are easy to obtain and convenient for monitoring.Therefore,the clinical characteristics of nasopharyngeal lymphoma,the predicative value of tumor microenvironment and peripheral blood inflammatory indicators for the lymphoma prognosis were reviewed.
作者 林福智 胡海霞 叶斌 向明亮 LIN Fuzhi;HU Haixia;YE Bin;XIANG Mingliang(Department of Otolaryngology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China)
出处 《中国眼耳鼻喉科杂志》 2021年第5期399-401,共3页 Chinese Journal of Ophthalmology and Otorhinolaryngology
基金 国家自然科学基金项目(81670926,91949119) 上海市科技支撑计划项目(15411950303,14DZ2260300) 上海市科技人才计划项目(扬帆计划、19YF1430300)。
关键词 鼻咽淋巴瘤 肿瘤微环境 外周血炎症指标 预后 Nasopharyngeal lymphoma Tumor microenvironment Peripheral blood inflammatory indicators Prognosis
  • 相关文献

参考文献5

二级参考文献23

  • 1袁智勇,李晔雄,赵路军,高远红,刘新帆,顾大中,钱图南,余子豪.鼻咽非霍奇金淋巴瘤的临床与预后分析[J].中华肿瘤杂志,2004,26(7):425-429. 被引量:16
  • 2姚波,李晔雄,宋永文,金晶,刘跃平,王维虎,王淑莲,孙耘田,余子豪,刘新帆.原发鼻腔非霍奇金淋巴瘤的治疗选择和疗效[J].中华肿瘤杂志,2006,28(1):58-61. 被引量:14
  • 3何艳姣,贾心善,莲井和久,王恩华,何安光.鼻及咽部非霍奇金淋巴瘤158例临床特点及其与EB病毒感染的关系[J].中华病理学杂志,2007,36(2):94-97. 被引量:14
  • 4Tse E,Kwong Y L.How I treat NK/T-cell lymphomas[J].Blood,2013,121(25):4997-5005.
  • 5Xu P P,Wang Y,Shen Y,et al.Prognostic factors of Chinese patients with T/NK-cell lymphoma:a single institution study of 170 patients[J].Med Oncol,2012,29(3):2176-2182.
  • 6Xu-Monette Z Y,Wu L,Visco C,et al.Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP:report from an International DLBCL Rituximab-CHOP Consortium Program Study[J].Blood,2012,120(19):3986-3996.
  • 7Nyman H,Adde M,Karjalainen-Lindsberg M L,et al.Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy[J].Blood,2007,109(11):4930-4935.
  • 8Mikhaeel N G.Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma:where are we now[J].Leuk Lymphoma,2009,50(12):1931-1936.
  • 9Moore M M,Chua W,Charles K A,et al.Inflammation and cancer:causes and consequences[J].Clin Pharmacol Ther,2010,87(4):504-508.
  • 10Wilcox R A,Ristow K,Habermann T M,et al.The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma[J].Leukemia,2011,25(9):1502-1509.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部